About this trial
This cross-sectional study aims to determine the prevalence of lactose intolerance among patients with chronic diarrhea, assess its correlation with age and gender, and evaluate common symptoms in affected patients. The study will collect demographic data, conduct lactose intolerance testing via PCR, and use a symptom questionnaire.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Related to defecation (pain improves or worsens with bowel movements).
Change in stool frequency (diarrhea or constipation).
Change in stool form (appearance) (loose, watery, hard, or lumpy).
Patients aged >18 years.
Disqualifiers
-patient aged<18 years old.
Patients with chronic diarrhea don't meet Rome criteria
patients with malignancies
Trial population
The study population consists of adult patients aged 18-70 years diagnosed with chronic diarrhea lasting more than four weeks. Both male and female participants are included. Participants will be recruited from a single healthcare center. They will undergo comprehensive assessments, including demographic profiling, medical history review, and diagnostic testing for lactose intolerance using PCR. The diversity in age and gender ensures that potential correlations with these variables can be analyzed.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Prevalence data on lactose intolerance in patients with IBS diarrhea dominant.
The primary outcome is to determine the percentage of patients with chronic diarrhea who test positive for lactose intolerance using PCR testing.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: